| Overview |
| bsm-61198r-apc-cy7-100ul |
| Phospho-CDK1/2 (Thr14) Recombinant Antibody, APC-Cy7 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| APC-Cy7 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CDK1 around the phosphorylation site of T14 |
| Thr14 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 983 |
| P06493,P24941 |
| Cytoplasm, Nucleus |
| CDC28; CDC2A; CDK1; Cell division control protein 2 homolog; Cyclin-dependent kinase 1; MPF; kinase Cdc2; p34 protein kinase. |
| Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition via association with multiple interphase. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz